fbpx An update on Mmr | Page 234 | Science in the net

An update on Mmr

Primary tabs

Read time: 1 min

Measles, mumps and rubella outbreaks still represent an healthcare issue, even though major advancements have been done towards their eradication. A poor inclination towards Mmr (measles-mumps-rubella) vaccination may constitute a major cause of increased risk to contract one of these diseases amongst specific population groups like migrants, alternative medicine users, some religious groups, healthcare professionals.
Information on Mmr vaccines coverage amongst these and others “hard-to-reach” groups was included in a document made and published Ecdc in range of the European project Venice II (Vaccine European New Integrated Collaboration Effort II). Main aim of the document was to provide a complete review of measles, mumps and rubella focuses which have been reported in the last twenty years in Europe.

Autori: 
Sezioni: 
Indice: 
Vaccination

prossimo articolo

Science and innovation in Italy: some figures to understand

Despite Italy investing so little in research, Italian researches are holding on, at least if we consider the number of cited publications at international level. What is critical, however, is the following step: from research to industrial applications, as shown from patents, start-ups and other indicators statistics. Yet, it is the combination of research, innovation, industrial dynamism and capability of winning new markets that can really “re-start” our Country, recovering employment and withstanding the more and more intense international competition.